-
1
-
-
0026545256
-
Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury
-
George M, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992; 262: H616-H620.
-
(1992)
Am J Physiol
, vol.262
-
-
George, M.1
Sherman, M.P.2
Buckberg, G.D.3
Haybron, D.M.4
Young, H.H.5
Ignarro, L.J.6
-
2
-
-
0024300153
-
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
-
Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251-6.
-
(1988)
Biochem Biophys Res Commun
, vol.153
, pp. 1251-1256
-
-
Palmer, R.M.1
Rees, D.D.2
Ashton, D.S.3
Moncada, S.4
-
3
-
-
0024463534
-
Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: Operative techniques and objectives
-
Buckberg GD. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Thorac Cardiovasc Surg 1989; 4: 216-38.
-
(1989)
J Thorac Cardiovasc Surg
, vol.4
, pp. 216-238
-
-
Buckberg, G.D.1
-
4
-
-
0029115088
-
Update on current techniques of myocardial protection
-
Buckberg GD. Update on current techniques of myocardial protection. Ann Thorac Surg 1995; 60: 805-14.
-
(1995)
Ann Thorac Surg
, vol.60
, pp. 805-814
-
-
Buckberg, G.D.1
-
5
-
-
0026639191
-
Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions
-
de Graaf JC, Banga JD, Moncada S, Palmer RMJ, de Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284-90.
-
(1992)
Circulation
, vol.85
, pp. 2284-2290
-
-
de Graaf, J.C.1
Banga, J.D.2
Moncada, S.3
Palmer, R.M.J.4
de Groot, P.G.5
Sixma, J.J.6
-
6
-
-
0027055170
-
Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size
-
Nakanishi K, Vinten-Johansen J, Lefer DJ, et al. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 1992; 263: H1650-H1658.
-
(1992)
Am J Physiol
, vol.263
-
-
Nakanishi, K.1
Vinten-Johansen, J.2
Lefer, D.J.3
-
7
-
-
0032826058
-
L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts
-
Kronon MT, Allen BS, Halldorsson A, Rahman S, Wang T, Ilbawi M. L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts. J Thorac Cardiovasc Surg 1999; 118: 665-73.
-
(1999)
J Thorac Cardiovasc Surg
, vol.118
, pp. 665-673
-
-
Kronon, M.T.1
Allen, B.S.2
Halldorsson, A.3
Rahman, S.4
Wang, T.5
Ilbawi, M.6
-
8
-
-
0031731634
-
L-arginine-induced vasodilatation in healthy humans: Pharmacokinetic-pharmacodynamic relationship
-
Bode-Boger SM, Boger RH, Galland A, Tsikas D, Frolich JC. L-arginine-induced vasodilatation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 1998; 46: 489-97.
-
(1998)
Br J Clin Pharmacol
, vol.46
, pp. 489-497
-
-
Bode-Boger, S.M.1
Boger, R.H.2
Galland, A.3
Tsikas, D.4
Frolich, J.C.5
-
9
-
-
0029120569
-
Acute effect of L-arginine on hemodynamics and vascular capacitance in the canine pacing model of heart failure
-
Ogilvie RI, Zborowska-Sluis D. Acute effect of L-arginine on hemodynamics and vascular capacitance in the canine pacing model of heart failure. J Cardiovasc Pharmacol 1995; 26: 407-13.
-
(1995)
J Cardiovasc Pharmacol
, vol.26
, pp. 407-413
-
-
Ogilvie, R.I.1
Zborowska-Sluis, D.2
-
10
-
-
0023254630
-
Endothelium derived relaxing factor inhibits in vitro platelet aggregation
-
Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90: 687-92.
-
(1987)
Br J Pharmacol
, vol.90
, pp. 687-692
-
-
Furlong, B.1
Henderson, A.H.2
Lewis, M.J.3
Smith, J.A.4
-
12
-
-
0013065280
-
Stress activated cytokines and the heart: From adaptation to maladaptation
-
Mann DL. Stress activated cytokines and the heart: from adaptation to maladaptation. Annu Rev Physiol 2003; 65: 81-101.
-
(2003)
Annu Rev Physiol
, vol.65
, pp. 81-101
-
-
Mann, D.L.1
-
13
-
-
0029365927
-
Tumor necrosis factor-alpha and the failing human heart
-
Oral H, Kapadia S, Nakano M, et al. Tumor necrosis factor-alpha and the failing human heart. Clin Cardiol 1995; 18 (Suppl 4): IV20-IV27.
-
(1995)
Clin Cardiol
, vol.18
, Issue.SUPPL. 4
-
-
Oral, H.1
Kapadia, S.2
Nakano, M.3
-
14
-
-
0029670957
-
Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
-
Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-11.
-
(1996)
Circulation
, vol.93
, pp. 704-711
-
-
Torre-Amione, G.1
Kapadia, S.2
Lee, J.3
-
15
-
-
0036187132
-
Cardioplegic arrest with L-arginine improves myocardial protection: Results of a prospective randomized clinical trial
-
Carrier M, Pellerin M, Perrault LP, et al. Cardioplegic arrest with L-arginine improves myocardial protection: results of a prospective randomized clinical trial. Ann Thorac Surg 2002; 73: 837-42.
-
(2002)
Ann Thorac Surg
, vol.73
, pp. 837-842
-
-
Carrier, M.1
Pellerin, M.2
Perrault, L.P.3
|